The Directorate General of Foreign Trade (DGFT) on August 03, 2026, notified regarding the Fixation of seven new Standard Input Output Norms (SIONs) at SION No. No. A-3708, A-3709, A-3710, A-3711, А-3712, A-3713 & A-3714 under "Chemical and Allied Product".
It has notified seven new Standard Input Output Norms (SIONs) under Product Group 'A' (Chemical and Allied Products) by inserting SION Nos. A-3708 to A-3714 under the Foreign Trade Policy (FTP), 2023. The newly notified norms specify the permissible import inputs and quantities for the manufacture and export of products including Theophylline (Anhydrous), Liraglutide Injection (6 mg/ml), Lumefantrine, Meropenem Injection (500 mg, 1000 mg and 2000 mg) and Ophthalmic Solution (Eye & Ear Drops).
The notification enables Regional Authorities to grant Advance Authorisations directly in eligible cases without referring individual applications to the Norms Committee, thereby reducing processing time, ensuring uniformity in fixation of norms and facilitating ease of doing business for exporters.
[Public Notice No. 23/2026-27]
